Tuberculosis, Multidrug-Resistant

Infectious Disease·MeSH: Tuberculosis, Multidrug-Resistant

7 drugs in development·1 company·4 clinical trials

Drug Pipeline by Phase

Phase 3(6)

Drug	Company
background regimen	GH Research PLC (GHRS)
conditioning regimen a	GH Research PLC (GHRS)
conditioning regimen b	GH Research PLC (GHRS)
conditioning regimen c	GH Research PLC (GHRS)
conditioning regimen d	GH Research PLC (GHRS)
conditioning regimen e	GH Research PLC (GHRS)

Phase 2(1)

Drug	Company
bedaquiline	GH Research PLC (GHRS)

Compare drugs

background regimen vs conditioning regimen a background regimen vs conditioning regimen b background regimen vs conditioning regimen c

Frequently asked questions

How many drugs are in development for Tuberculosis, Multidrug-Resistant?

BioSniper tracks 7 drugs in development for Tuberculosis, Multidrug-Resistant across 1 company.

How many clinical trials target Tuberculosis, Multidrug-Resistant?

There are 4 clinical trials targeting Tuberculosis, Multidrug-Resistant tracked by BioSniper.

Deep-dive into Tuberculosis, Multidrug-Resistant

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis

Tuberculosis, Multidrug-Resistant — Drugs in Development & Clinical Trials | BioSniper